538 related articles for article (PubMed ID: 18049474)
1. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
2. HCV and HIV: a tale of two viruses.
Sherman KE
Rev Gastroenterol Disord; 2004; 4 Suppl 1():S48-54. PubMed ID: 15185718
[TBL] [Abstract][Full Text] [Related]
3. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
4. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
5. Interaction between HIV-1 and HCV infections: towards a new entity?
Winnock M; Salmon-Céron D; Dabis F; Chêne G
J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
7. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
8. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
Endo T; Fujimoto K; Nishio M; Yamamoto S; Obara M; Sato N; Koike T
J Med Virol; 2009 Jun; 81(6):979-82. PubMed ID: 19382259
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
Núñez M; Soriano V
J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
[No Abstract] [Full Text] [Related]
10. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
11. HIV and hepatitis C co-infection.
Jones R; Dunning J; Nelson M
Int J Clin Pract; 2005 Sep; 59(9):1082-7. PubMed ID: 16115185
[TBL] [Abstract][Full Text] [Related]
12. HCV versus HIV drug discovery: Déjà vu all over again?
Watkins WJ; Desai MC
Bioorg Med Chem Lett; 2013 Apr; 23(8):2281-7. PubMed ID: 23489621
[TBL] [Abstract][Full Text] [Related]
13. Management of HCV and HIV infections among people who inject drugs.
Grebely J; Tyndall MW
Curr Opin HIV AIDS; 2011 Nov; 6(6):501-7. PubMed ID: 22001894
[TBL] [Abstract][Full Text] [Related]
14. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus: prospects for future therapies.
Wilkinson T
Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
17. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C viremia persistently suppressed by HAART.
Ranieri R; Santambrogio C; Veronelli A; Pontiroli AE
Clin Infect Dis; 2003 Apr; 36(8):1086-7. PubMed ID: 12684926
[No Abstract] [Full Text] [Related]
19. [HIV and HCV infections--clinical implications].
Pawłowska M; Halota W; Grabczewska E
Przegl Epidemiol; 2004; 58 Suppl 1():71-5. PubMed ID: 15807161
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the discovery of small molecule therapies for HCV.
Myles DC
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
